D.S.L., M.K.). The online-only Data Supplement is available at http://circheartfailure.ahajournals.org/lookup/suppl/
H eart failure (HF) is a complex, progressive syndrome characterized by abnormal heart function, resulting in reductions in both quality of life and survival. 1 Healthcare delivery models aimed at better control of HF have, therefore, been of particular interest. 2 Disease management through multidisciplinary community care clinics improves patient outcomes in multiple health conditions. 3, 4 Randomized studies have evaluated the efficacy of such clinics in HF with some suggesting that mortality is decreased. 1, 2, 5 An important limitation is the substantial heterogeneity in both the composition of the HF clinics studied, and the interventions offered. Moreover, there remains uncertainty about which components of specialized HF clinics are most important. For example, are beneficial effects mediated through more aggressive medication titration, or through enhanced surveillance?
Our objective was to address these important gaps in knowledge through a field evaluation, whereby we assessed real-world practice for HF patients in Ontario, Canada. Our specific aims were (1) to compare clinical effectiveness for the cohort of Ontario patients treated at specialized HF clinics with a cohort of HF patients treated with usual care and (2) identify which characteristics of HF clinic service models were associated with improved outcomes.
Data Sources
Ontario, which is Canada's most populous province, has >13 million residents who have universal access to physician and hospital services through a publicly funded healthcare program. Population-level administrative databases with information on all Ontario residents are available at the Institute for Clinical Evaluative Sciences. These databases were linked using encrypted unique patient identifiers, thereby protecting patient confidentiality, whereas allowing for the longitudinal evaluation of clinical outcomes. The Canadian Institute for Health Information discharge abstract database contains data on all hospitalizations in the province. The Canadian Institute for Health Information discharge abstract database record includes the most responsible diagnosis and up to 24 additional diagnoses codes that can be used to estimate comorbidity. The Ontario Registered Persons Database was used to ascertain mortality. Data on physician visits and consultations were obtained from the fee-for-service claims history in Ontario Health Insurance program database. 6
Study Design and Sample
We performed a cohort study of patients discharged alive after a HF hospitalization from April 1, 2006, to March 31 2007, comparing patients treated in HF clinics with a matched control cohort not treated in HF clinics. Patients were identified based on International Classification of Disease Version 10 code I50, as the most responsible diagnosis in the Canadian Institute for Health Information discharge abstract database. We included all patients older than 20 years who were Ontario residents with valid health insurance numbers. If a patient had >1 HF hospitalization during this period, the first hospitalization was selected as the index event.
We categorized patients as HF clinic patients based on the presence of an Ontario Health Insurance program claim for HF by 1 of 91 identified HF clinic physicians in Ontario, occurring after hospital discharge and within 1 year of the index event. HF clinic physicians were identified in an environmental scan of HF clinics across Ontario conducted by our group. 7 In the previous study, HF clinics were defined as a clinic consisting of a minimum of a physician and a nurse, one of whom had specialized training and interest in HF. Once identified, interviews were conducted at the HF clinic, to confirm that they met this definition, and to evaluate the service components of the clinic. Any patient who was not seen by a HF clinic physician was categorized as a control patient. Control patients received usual care which may have been no follow-up at all, or follow-up with a family physician, internist, or cardiologist.
We used a validated instrument, the HF Disease Management Scoring Instrument (HF-DMSI), to score the intensity of each HF clinic across 10 categories (see Appendix I in the online-only Data Supplement). 8 Because the HF-DMSI does not provide an overall score, it is not possible to rank clinics based on this alone. Therefore, we performed a concept mapping exercise, using a HF expert panel. 7 The expert panel determined the relative importance of each of the 10 categories of the HF-DMSI and then, using this implicit weighting, categorized the clinics into 3 intensity strata (high, medium, and low). 7 Of the 91 HF clinic physicians in practice in 2006-2007 in Ontario, 74 (81%) consented to having their Ontario Health Insurance program billing numbers used for this study. To mitigate potential misclassification bias, we excluded patients discharged from the 6 hospitals in which the nonconsenting HF clinic physicians practiced.
Outcomes
Outcomes were evaluated until March 31, 2010. The primary effectiveness outcome was all-cause mortality. Secondary outcomes were all-cause readmission and hospitalization for HF.
Statistical Analyses
Given the observational nature of our study, we used propensity-score methods to account for anticipated differences between HF clinic and non-HF clinic cohorts. Propensity-score methods are an analytic approach to minimize the effect of measured confounding factors. [9] [10] [11] [12] We fitted a multivariable logistic regression model, where the exposure was having been seen by a HF clinic physician (Appendix II in the online-only Data Supplement). 13 We used this model to calculate a propensity-score of the predicted probability of being in a HF clinic. We then created a propensity-score-matched cohort by matching each patient in the HF clinic cohort with one in the control cohort (a 1:1 match). 9,10 A greedy nearest-neighbor-matching algorithm was used to match each HF clinic patient to the nearest control patient on the basis of the logit of their propensity-score, with matching occurring if the difference in the logit was <0.2× the SD of the scores (the calliper width). 9, 10 Standardized differences of the mean (<0.1) were used to indicate good balance in the matched sample. 10, 14 Kaplan-Meier survival curves for each primary and secondary outcome were estimated for the matched HF clinic and control cohorts, initiated at the time of discharge from the index hospitalization. 10 Differences between survival curves were compared using the stratified log-rank test to account for the matched nature of the sample. 10, 15, 16 To explore the characteristics of HF clinics that were associated with improved outcomes, Cox-proportional hazard models were developed, restricted to the entire HF clinic population. The unit of analysis for these models was the patient. Robust variance estimates were obtained to account for the clustering of patients within HF clinics. We created separate models with all-cause mortality, all-cause readmission, and HF readmission as the dependent variable. To adjust for patient-level comorbidities, we used the variables described for the hierarchical regression model developed by Krumholz et al 17 for patients with HF using Medicare claims data (Appendix III in the online-only Data Supplement).
After adjustment for patient-level comorbidities, clinic-level covariates were forced into the regression. Because of concerns about the possibility of multicollinearity, the effects of the scores on the HF-DMSI instrument and the clinic intensity strata were estimated in separate models. The final model included only HF-DMSI categories that were statistically significant when evaluated individually.
Sensitivity Analyses

LV Function
Studies show that HF patients with preserved left-ventricular (LV) function (ie, LV function >45%) have improved survival compared with patients with reduced LV function. LV function data are not available in administrative databases. Propensity-score methods may not necessarily balance all unmeasured confounders. 9 To test the degree to which our propensity-match balanced LV function between HF clinic and control patients, we repeated the above propensity-score in a separate cohort of 9943 patients from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study, which contained both administrative data and clinical data on LV function. 18
Survivorship Bias
Our HF clinic definition required survival until assessment by a HF clinic physician. We performed 3 sensitivity analyses to evaluate the impact of survivorship bias. We did 2 landmark analyses, restricting our analysis to patients who survived at least (1) 30 days and (2) 1 year after discharge. We also performed an analysis, whereby we used the date of being seen by a HF clinic physician as the start date for each HF clinic patient. We randomly assigned start dates to control patients, such that the distribution of the interval between index hospital discharge and start date was identical for both cohorts. We excluded any control patient who died before their assigned start date, and then repeated the propensity match. All analyses were performed using SAS Version 9.2 (SAS Institute, Inc, Cary, NC).
Results
Study Sample
From April 2006 to March 2007, 16 300 patients were admitted to hospitals in Ontario with a primary diagnosis of HF. When restricted to patients older than the age of 20, with valid Ontario health card numbers, and to patients who survived until discharge, our sample size was 14 468. Of these patients, 1288 were seen by HF clinic physicians within 1 year of their index discharge, with 10 996 control patients (Figure 1 ). Among the HF clinic patients, there was a substantial range in the frequency of HF clinic physician visits compared with other non-HF clinic physicians. On average, HF clinic visits represented 15% of all physician visits (median, 9.2%; intraquartile range; 2.7%-21.3%).
Of the 14 468 patients alive after discharge, 2184 patients were excluded (13% of overall group) because they were discharged from institutions with incomplete HF physician billing data and, therefore, could not be accurately classified.
Baseline Characteristics
Before matching, these 2 cohorts were substantially different ( Table 1) . Patients in HF clinics tended to be younger, with a mean age of 71.8 years (SD, 13.4), compared with 77.0 years (SD, 11.5) for control patients. More males (60.1% versus 47.9%) were seen in HF clinics compared with control. There were substantial differences in residence and socioeconomic status, with more urban (92.5% versus 80.9%) and higher income patients in HF clinics. In general, control patients had more comorbidities. Appendix II in the online-only Data Supplement, the components of the propensity-score used to match HF clinic and control patients are detailed. We found that older patients were less likely to be seen in HF clinic (odds ratios, 0.969 for each year increase in age; P<0.0001), whereas males were more likely to be referred to HF clinic (odds ratios, 1.34; P<0.0001). The strongest predictor of being seen in a HF clinic was geographic region with odds ratios in the 50 to 150 range depending on region, suggesting that regional inequality in access was a major driver for why patients were not seen in the clinic.
In Table 2 , the baseline characteristics of HF clinic and control patients after propensity matching are shown. All 1288 patients with HF were successfully matched to control patients. There was good balance between the 2 groups with standardized differences <0.1. There was complete follow-up until March 31, 2010, for all patients.
Clinical Outcomes
During the 4 years of follow-up, all-cause mortality was 52.1% in the HF clinic cohorts compared with 54.7% in the control group, which was statistically significant, with a P value of 0.02 ( Figure 2) . In contrast, the HF clinic group had greater rates of both all-cause readmission (87.4% versus 86.6%; P=0.009) and HF readmission (58.7% versus 47.3%; P<0.001,) in comparison with the control patients.
HF Clinic Characteristic Associated With Improved Outcome
The 1288 HF clinic patients were seen at 21 HF clinics, of which 8 were classified as high intensity clinics, 8 medium intensity clinics, and 5 as low intensity clinics. The intensity scores of these clinics based on the HF-DMSI are summarized in Appendix IV in the online-only Data Supplement. We did not find any statistically significant relationship between HF clinic intensity strata and mortality or all-cause and HF readmission (Appendix V in the online-only Data Supplement).
The relationship of these clinic-level scores on the HF-DMSI and outcomes is shown in Table 3 . Higher complexity clinics, with >4 contacts between providers and patients, had a significant reduction in mortality (hazard ratio, 0.14; 95% confidence interval, 0.08-0.25; P<0.001) compared with clinics with only a single contact with little or no follow-up.
A more intensive medication management program was associated with reduced all-cause and HF readmission (hazard ratio, 0.46 and hazard ratio, 0.42, respectively). Higher complexity clinics with >4 provider-patient contacts were also associated with a reduction in hospitalization (hazard ratio, 0.69; P=0.039). However, greater involvement of caregivers, or a more comprehensive education program on supporting self care, was associated with increased hospitalization (Table 3 ).
Sensitivity Analyses
Quality of Matching Between HF Clinic Patients and Control Patients
When the matching algorithm was applied to the EFFECT study cohort, there was some imbalance in LV function between HF clinic patients and control patients (Appendix VI online-only Data Supplement). The proportion of patients with preserved left ventricular ejection fraction was higher in the control group than in the HF clinic group (22.5% versus 16.7%). 
Survivorship Bias
These results are found in Appendix VII in online-only Data Supplement. In all 3 analyses, there was no statistically significant difference between survival in the HF clinic group and the control group. However, the findings for hospitalization were robust.
Discussion
In this population-based comparison of patients with HF treated at specialized HF clinics versus control, we found that only ≈10% of patients with HF were seen at specialized HF clinics after hospital discharge. Treatment at HF clinics was associated with a small but statistically significant reduction in mortality, but increased all-cause and HF readmissions. HF clinics have been studied extensively in the literature as a preferred mode of ambulatory care delivery to patients with this complex condition. Despite this, our study showed that a minority of patients are actually treated in HF clinics. Indeed, our analysis found substantial regional differences in access, with patients in different regions having a 150-fold difference in being treated in HF clinics. This is consistent with our previous environmental scan that showed large geographic disparities in the number of clinics per capita. 7 Meta-analyses of randomized controlled trials have generally shown that these clinics are associated with an improvement in mortality, with most showing an improvement in hospitalization when compared with control. 1, 2, 5, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] We found similar improvements in mortality, albeit of a smaller magnitude. 2, 27 It is important to note the potential for survivorship bias in our study. The survival curves for the HF clinic and control patients separated early, and in our sensitivity analyses, this mortality difference was no longer significant. It is reassuring that previous investigators evaluating specialist care for patients with HF, using a time-varying covariate design to account for survivorship bias, have found similar mortality findings. 34 Nonetheless, given these limitations, readers should exercise caution in interpreting the mortality differences we observed. In contrast, the findings on hospitalization were robust in all analyses. Unlike other trials, we found an increase in hospitalizations. 27 There are several potential explanations for our findings. Ours is an observational study; although we used advanced statistical methods to mitigate this, persistent confounding is likely to remain, because we were limited to data contained in administrative databases and did not have access to other important clinical variables, such as LV function and symptom severity that have important impact on clinical decision-making and prognosis. 9 Most importantly, the clinics in Ontario may not be representative of those evaluated in clinical trials. Indeed, in our previous work, we found a wide spectrum of service models in Ontario. Notably, the identified HF clinics were principally focused on outpatient care, with no in-hospital or home-based components. Several studies suggest that hospital discharge planning and a home-based intervention may be critical components necessary to reduce hospitalizations. 27, 35 The large sample size of our study affords the opportunity to evaluate the association between clinic-level characteristics and outcomes. We found that the most important clinic-level characteristic was the frequency and complexity of providerpatient contact. Of note, intensity of medication management and the comprehensiveness of the education program did not seem to be significant factors in reducing mortality, although medication management reduced hospitalization.
This finding is contrary to some of the prevailing hypotheses on the mechanism of benefit of HF clinics, which suggest that HF clinics principally improve medication utilization and compliance. Instead, our results suggest, through involvement of the caregiver and improved education, there is better surveillance and potential for earlier intervention. In this analysis, caregiver involvement, in addition to more comprehensive education, was associated with more hospitalization, suggesting that the greater screening leads to earlier intervention that seems to be hospital based. This is similar to work from other investigators, which has shown that greater access to outpatient primary care is associated with increased hospitalization. 36, 37 These counterintuitive findings provide new insight into the care of these patients in Ontario. They suggest that the mortality benefit afforded by HF clinics may be mediated in part by earlier hospitalization and intervention, and thus avoidance of critical deterioration. In this setting, one can argue that these hospitalizations are not avoidable, but may be an important mediator of improved survival. Balanced against this are the substantial cost implications of the higher HF readmission rates among HF clinic patients, which may impact the cost-effectiveness of this mode of ambulatory care delivery. Our group has previously evaluated this issue using literature estimates to model the costs and outcomes for HF clinic patients. 38 Based on these estimates from randomized Please see Appendix I in the online-only Data Supplement for definitions of scores on clinic-level characteristics. All analyses were first adjusted for patient-level covariates, as listed in Appendix III in the online-only Data Supplement. CI indicates confidence interval; HF, heart failure; and HR, hazard ratio. trials, which showed a statistically significant survival benefit associated with HF clinics, but a nonsignificant trend toward increased hospitalization, we concluded that HF clinics were a cost-effective intervention. Repeating these analyses using the real-world estimates from our current study is an area of active research for our group.
Our study must be interpreted in the context of several limitations that merit discussion. First, as elaborated, there is the possibility of survivorship bias. Second, we did not have information on LV function. Moreover, based on the EFFECT analysis, LV function was likely not balanced. However, patients with preserved LV tend to have improved survival; as such, we are likely underestimating the survival benefit afforded by HF clinics. In addition, we did not have access to other clinically important variables, such as patient education status, and HF symptom severity, as quantified by New York Heart Association severity. Finally, we classified HF clinic patients using physician billing numbers, assuming that all patients with HF seen by a HF clinic physician are seen in a HF clinic. This may not be true; nonetheless, it is likely that the care provided by a HF clinic physician to HF patients seen outside of a formal HF clinic is comparable with those in the HF clinic. In addition, any error introduced by potential misclassification of non-HF clinic patients would result in a bias toward the null, suggesting that we are underestimating the true effect of HF clinics.
In conclusion, we found that HF clinics are associated with an increase in rehospitalizations, most notably HF readmissions. There is a complex relationship between the complexity of HF clinic services and health outcomes; this is highly relevant to policy makers and clinicians when designing such clinics.
